GL1X · GenesisL1 explorer

Research workbench

Design, synthesis, and biological evaluation of pyrazolopyridine- sulfonamides as potent multiple-mitotic kinase (mmk) inhibitors (part I)

Analyse Design, synthesis, and biological evaluation of pyrazolopyridine- sulfonamides… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3R22
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase 6
EC
2.7.11.1
UniProt
O14965
Ligands
D37
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase 6 (EC 2.7.11.1)protein25540% helix, 18% strandO14965

Ligands and binding sites

  • D37 · N-{5-[(1-cycloheptyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino]pyridin-2-yl}methanesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13260.640.7943D37

Compared structures

  • 3R22 · Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent… · the same entry in another collection · chain A against A, TM-score 1.00
  • O14965 · AlphaFold monomer V2.0 prediction for aurora kinase a (O14965) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.